Phase 2 Apatinib Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma

MelanomaAcral MelanomaNeoadjuvant+4 more

Peking University Cancer Hospital & Institute60 enrolled1 locationNCT05512481

Recruiting

Phase 2

DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma

Intrahepatic CholangiocarcinomaApatinibTransarterial Chemoembolization+1 more

Sichuan Cancer Hospital and Research Institute20 enrolled1 locationNCT04834674